Three-Year Results of a Randomized, Double-Blind, Controlled Trial of Mycophenolate Mofetil Versus Azathioprine in Cardiac Transplant Recipients

MLA

Anne Keogh, et al. “Three-Year Results of a Randomized, Double-Blind, Controlled Trial of Mycophenolate Mofetil Versus Azathioprine in Cardiac Transplant Recipients.” The Journal of Heart and Lung Transplantation, vol. 24, May 2005, pp. 517–25. EBSCOhost, https://doi.org/10.1016/j.healun.2005.02.002.

APA

Anne Keogh, Whedy Wang, Manfred Hummel, Donna Mancini, Maria Rosa Constanzo, Hannah A. Valantine, Robert M. Mentzer, Mandeep R. Mehra, Robert C. Bourge, Edwin L. Alderman, Jon A. Kobashigawa, Howard J. Eisen, Robert D. Gordon, Dale G. Renlund, Georges Dureau, Richard D. Mamelok, & Jay A. Johnson. (2005). Three-Year Results of a Randomized, Double-Blind, Controlled Trial of Mycophenolate Mofetil Versus Azathioprine in Cardiac Transplant Recipients. The Journal of Heart and Lung Transplantation, 24, 517–525. https://doi.org/10.1016/j.healun.2005.02.002

Chicago

Anne Keogh, Whedy Wang, Manfred Hummel, Donna Mancini, Maria Rosa Constanzo, Hannah A. Valantine, Robert M. Mentzer, et al. 2005. “Three-Year Results of a Randomized, Double-Blind, Controlled Trial of Mycophenolate Mofetil Versus Azathioprine in Cardiac Transplant Recipients.” The Journal of Heart and Lung Transplantation 24 (May): 517–25. doi:10.1016/j.healun.2005.02.002.